5 Highest Paid Biopharma CEOs of 2016
The New York Times recently published a list of the 200 highest paid chief executive officers in the United States as researched and reported by Equilar. Check out where the top five biopharma CEOs ranked on that list:
1. Leonard Schleifer, Regeneron Pharmaceuticals
Ranked #7 with $47.5 million in total compensation.
2. Jeffery Leiden, Vertex Pharmaceuticals
Ranked #20 with $28.1 million in total compensation.
3. Robert Hugin, Celgene
Ranked #36 with $22.5 million in total compensation.
4. Brent Saunders, Allergan
Ranked #43 with $21.6 million in total compensation.
5. Alex Gorsky, Johnson & Johnson
Ranked #46 with $21.1 million in total compensation.
